CSI Singapore

CSI Singapore To better understand the causes of human cancer across Asia, thereby improve its detection, treatment and prevention.

CSI Singapore would like to welcome onboard Dr. Peter Yeow to our CSI community 👏 His research focus is  targeting cance...
07/10/2025

CSI Singapore would like to welcome onboard Dr. Peter Yeow to our CSI community 👏 His research focus is targeting cancer cell division and TRIM E3 ligases.

Read more about him: https://csi.nus.edu.sg/researcher/peteryeow/

We are pleased to announce that the CSI Singapore – Kyoto University Joint Symposium 2025 will be taking place from 24 t...
06/10/2025

We are pleased to announce that the CSI Singapore – Kyoto University Joint Symposium 2025 will be taking place from 24 to 26 November 2025 at the National University of Singapore (NUS).

This three-day symposium will bring together leading researchers from both institutions to exchange insights and foster collaborations in cancer science and biomedical research.

📌 Please save the date!

🎉 Congratulations to our outstanding researchers!We are proud to announce that several of our researchers have been feat...
30/09/2025

🎉 Congratulations to our outstanding researchers!
We are proud to announce that several of our researchers have been featured in the Top 2% Most Cited Scientists list, a prestigious global database compiled by Stanford University and published by Elsevier.
This recognition reflects their exceptional research impact and continued contributions to advancing knowledge in their fields.
👏 We celebrate your dedication, innovation, and excellence!

On World Cancer Research Day, we reflect on the courage of patients and families navigating the cancer journey — and the...
24/09/2025

On World Cancer Research Day, we reflect on the courage of patients and families navigating the cancer journey — and the importance of research in bringing hope and better outcomes.

The Straits Times has featured the voices of patients alongside Prof Wee Joo Chng, Principal Investigator at CSI Singapore, whose work in blood cancers like multiple myeloma continues to push boundaries in treatment and care.

At CSI Singapore, our mission is simple but powerful: transform cancer care through science and innovation — for Singapore and beyond.

📣 A big thank you to everyone who stopped by our CSI Core Facilities Roadshow last Wednesday (17 September)!Our teams ha...
23/09/2025

📣 A big thank you to everyone who stopped by our CSI Core Facilities Roadshow last Wednesday (17 September)!

Our teams had a great time sharing how our cutting-edge platforms – from Flow Cytometry and Genome Engineering to Quantitative Proteomics, Spatial Biology, and Genomic Data Analytics – can support and accelerate research.

It was inspiring to see the enthusiasm and exchange of ideas. Here’s to advancing science together! 💡

Interested in Pursuing a PhD in Cancer Biology? Join us for an exclusive CSI Graduate Program Virtual Sharing Session!Di...
23/09/2025

Interested in Pursuing a PhD in Cancer Biology? Join us for an exclusive CSI Graduate Program Virtual Sharing Session!
Discover the exciting opportunities offered by the CSI Graduate Program and learn about the scholarship available for successful applicants. Hear directly from current scholars as they share their research journeys and experiences. Plus, get your questions answered by members of the CSI Education and Training Committee!
Don't miss this chance to explore your future in cancer biology research.

Last week, CSI Singapore hosted Dr. Michel Steinmetz from  Paul Scherrer Institut. He spoke on the topic “Microtubule-me...
19/09/2025

Last week, CSI Singapore hosted Dr. Michel Steinmetz from Paul Scherrer Institut. He spoke on the topic “Microtubule-mediated Signal Transduction and Interactions with Anticancer Drugs”.

📣 *CSI Core Facilities* are going on the road this Wed (17 Sep)—catch us along the walkway to the Science Canteen!Come c...
15/09/2025

📣 *CSI Core Facilities* are going on the road this Wed (17 Sep)—catch us along the walkway to the Science Canteen!
Come chat with our team about experiment design, methods, and troubleshooting. See you there!

Treating patients whose non-Hodgkin’s lymphoma (NHL) has come back or stopped responding to therapy remains very difficu...
11/09/2025

Treating patients whose non-Hodgkin’s lymphoma (NHL) has come back or stopped responding to therapy remains very difficult. Many eventually run out of standard treatment options. A team led by Dr. Anand Jeyasekharan and Dr. Edward Chow (NCIS & CSI Singapore, NUS) tested a new approach using an artificial intelligence tool called the Quadratic Phenotypic Optimisation Platform (QPOP).

This tool takes a patient’s cancer cells, tests them against different drug combinations outside the body, and then uses AI to predict which treatments are most likely to work. In one of the largest ex vivo drug testing studies to date, involving 117 patients, QPOP was able to correctly predict treatment response in about 3 out of 4 cases.

Patients who went on to receive QPOP-guided, personalised treatment had a 59% response rate, and about 60% of them stayed well for longer compared to their previous treatment. After two years, patients in the QPOP-guided group lived significantly longer without their disease worsening, with a 44% lower risk of progression compared to those who received standard salvage chemotherapy.

These findings suggest that QPOP could become a powerful tool to help doctors match the right drug combinations to the right patients, bringing renewed hope to patients facing limited options.

PURPOSEDespite initially responding to first-line treatment, many patients with non-Hodgkin's lymphoma (NHL) eventually relapse or are refractory. These patients are empirically subjected to salvage therapies that may not be efficacious. We had previously ...

Address

14 Medical Drive, Centre For Translational Medicine, #12/01
Singapore
117599

Opening Hours

Monday 09:00 - 17:00
Tuesday 09:00 - 17:00
Wednesday 09:00 - 17:00
Thursday 09:00 - 17:00
Friday 09:00 - 17:00

Telephone

+6565165394

Alerts

Be the first to know and let us send you an email when CSI Singapore posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram